| Date | Name | Symbol | Type | Security | Shares | Price | Value | Ownership | Reported |
| 01/03/2023 | Salarius Pharmaceuticals, Inc. | FLKS | Grant | Common Stock | 8k | $0.00 | $0 | | 01/03/2023 |
| 11/03/2022 | Salarius Pharmaceuticals, Inc. | FLKS | Grant | Common Stock | 7.3k | $1.73 | $12.7k | | 11/03/2022 |
| 11/03/2022 | Salarius Pharmaceuticals, Inc. | FLKS | Grant | Common Stock | 7.3k | $1.73 | $12.7k | | 11/03/2022 |
| 11/03/2022 | Salarius Pharmaceuticals, Inc. | FLKS | Grant | Common Stock | 1.5k | $1.73 | $2.6k | | 11/03/2022 |
| 05/31/2022 | Salarius Pharmaceuticals, Inc. | FLKS | Purchase | Common Stock | 28k | $0.18 | $5k | | 05/31/2022 |
| 05/03/2022 | Salarius Pharmaceuticals, Inc. | FLKS | Grant | Common Stock | 10k | $0.19 | $1.9k | | 05/03/2022 |
| 03/03/2022 | Salarius Pharmaceuticals, Inc. | FLKS | Purchase | Common Stock | 76.2k | $0.39 | $29.8k | | 03/03/2022 |
| 01/20/2022 | Salarius Pharmaceuticals, Inc. | FLKS | Grant | Stock Option (right to buy) | 200k | $0.48 | $96k | | 01/20/2022 |
| 11/03/2021 | Salarius Pharmaceuticals, Inc. | FLKS | Grant | Common Stock | 7.8k | $0.72 | $5.6k | | 11/03/2021 |
| 05/03/2021 | Salarius Pharmaceuticals, Inc. | FLKS | Grant | Common Stock | 9.6k | $0.57 | $5.4k | | 05/03/2021 |
| 12/02/2020 | Salarius Pharmaceuticals, Inc. | FLKS | Grant | Stock Option (right to buy) | 80k | $0.74 | $59.2k | | 12/02/2020 |
| 11/03/2020 | Salarius Pharmaceuticals, Inc. | FLKS | Grant | Common Stock | 4.7k | $0.56 | $2.6k | | 11/03/2020 |
| 08/17/2020 | Salarius Pharmaceuticals, Inc. | FLKS | Purchase | Common Stock | 5k | $1.00 | $5k | | 08/17/2020 |
| 07/14/2020 | Salarius Pharmaceuticals, Inc. | FLKS | Grant | Stock Option (right to buy) | 50k | $1.32 | $65.9k | | 07/14/2020 |
| 03/23/2020 | Salarius Pharmaceuticals, Inc. | FLKS | Grant | Common Stock | 30k | $0.61 | $18.3k | | 03/23/2020 |
| 02/19/2020 | Salarius Pharmaceuticals, Inc. | FLKS | Purchase | Common Stock | 2k | $0.95 | $1.9k | | 02/19/2020 |
| 02/13/2020 | Salarius Pharmaceuticals, Inc. | FLKS | Purchase | Common Stock | 5k | $0.86 | $4.3k | | 02/13/2020 |
| 01/31/2014 | Ayala Pharmaceuticals, Inc. | ADXS | Payment of Exercise | Common Stock | 48 | $4.49 | $215.5 | | 01/31/2014 |
| 01/31/2014 | Ayala Pharmaceuticals, Inc. | ADXS | Grant | Common Stock | 530 | $0.00 | $0 | | 01/31/2014 |
| 01/07/2014 | Ayala Pharmaceuticals, Inc. | ADXS | Payment of Exercise | Common Stock | 8.3k | $4.03 | $33.5k | | 01/07/2014 |
| 01/07/2014 | Ayala Pharmaceuticals, Inc. | ADXS | Grant | Common Stock | 80k | $0.00 | $0 | | 01/07/2014 |
| 01/07/2014 | Ayala Pharmaceuticals, Inc. | ADXS | Grant | Common Stock | 20k | $0.00 | $0 | | 01/07/2014 |
| 01/07/2014 | Ayala Pharmaceuticals, Inc. | ADXS | Payment of Exercise | Common Stock | 1.6k | $4.03 | $6.3k | | 01/07/2014 |
| 01/07/2014 | Ayala Pharmaceuticals, Inc. | ADXS | Grant | Common Stock | 3k | $0.00 | $0 | | 01/07/2014 |
| 10/31/2011 | Ayala Pharmaceuticals, Inc. | ADXS | Grant | Convertible Promissory Note | 0 | $0.15 | $0 | See Footnote | 10/31/2011 |
| 10/31/2011 | Ayala Pharmaceuticals, Inc. | ADXS | Grant | Common Stock Warrants (right to buy) | 196.1k | $0.15 | $29.4k | See Footnote | 10/31/2011 |
| 10/31/2011 | Ayala Pharmaceuticals, Inc. | ADXS | Grant | Convertible Promissory Note | 0 | $0.15 | $0 | See Footnote | 10/31/2011 |
| 10/31/2011 | Ayala Pharmaceuticals, Inc. | ADXS | Grant | Common Stock Warrants (right to buy) | 196.1k | $0.15 | $29.4k | See Footnote | 10/31/2011 |